Benemae Pharmaceutical

The National Medical Products Administration (NMPA) has indicated on its website that benaglutide, developed by Shanghai Benemae Pharmaceutical Co., Ltd, has been granted approval for adult weight management in China. This marks the second hypoglycemic drug approved for weight loss in the country, following Huadong Medicine Co., Ltd’s (SHE: 000963)…